ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides
Authors:
Open Access
- 10 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (3) , 382-383
Abstract
In the current ESC guidelines for the management of heart failure, 1 Dickstein et al. for the first time integrate B-type natriuretic peptides into a concrete diagnostic algorithm for patients with suspected first presentation of chronic heart failure. Patient presentation in this case most probably happens in primary care. Therefore, it seems uncommon that natriuretic peptides are recommended after echocardiographic assessment in the flow chart.Keywords
This publication has 4 references indexed in Scilit:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- N-Terminal Pro-Brain Natriuretic Peptide for Discriminating Between Cardiac and Non-Cardiac DyspnoeaEuropean Journal of Heart Failure, 2004
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002